XML 66 R52.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Stock Options, Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Payment Arrangement, Expense $ 513 $ 670 $ 1,703 $ 2,370  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]          
Weighted average exercise price, beginning of period (in dollars per share)     $ 2.91 $ 3.43 $ 3.43
Grants in period, weighted average exercise price (in dollars per share)     3.99   1.77
Exercises in period, weighted average exercise price (in dollars per share)     2.65   1.97
Forfeitures in period, weighted average exercise price (in dollars per share)     3.16   3.26
Expirations in period, weighted average exercise price (in dollars per share)     8.14   4.40
Weighted average exercise price, end of period (in dollars per share) $ 2.98   $ 2.98   $ 2.91
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Number of options, beginning of period (in shares)     1,609,087 1,487,433 1,487,433
Number of grants in period, net of forfeitures (in shares)     169,210   711,414
Number of exercises in period (in shares)     (615,591)   (302,707)
Number of forfeitures in period (in shares)     (8,049)   (188,541)
Number of expirations in period (in shares)     (51,653)   (98,512)
Number of options, end of period (in shares) 1,103,004   1,103,004   1,609,087
Employee Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Payment Arrangement, Expense $ 42 $ 134 $ 281 $ 508  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]          
Exercisable options, weighted average exercise price (in dollars per share) $ 3.06   $ 3.06    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Number of grants in period, net of forfeitures (in shares)       710,000  
Number of exercisable options (in shares) 888,627   888,627    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term     2 years 6 months 14 days    
Exercisable options, weighted average remaining contractual term     2 years 3 months    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $ 3,540   $ 3,540    
Minimum          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]          
Weighted average exercise price, beginning of period (in dollars per share)     $ 1.70 $ 1.70 $ 1.70
Grants in period, weighted average exercise price (in dollars per share)     3.89   1.76
Exercises in period, weighted average exercise price (in dollars per share)     1.70   1.70
Forfeitures in period, weighted average exercise price (in dollars per share)     1.76   1.70
Expirations in period, weighted average exercise price (in dollars per share)     1.70   4.12
Weighted average exercise price, end of period (in dollars per share) $ 1.70   1.70   1.70
Exercisable options, weighted average exercise price (in dollars per share) 1.70   1.70    
Maximum          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]          
Weighted average exercise price, beginning of period (in dollars per share)     15.61 $ 15.61 15.61
Grants in period, weighted average exercise price (in dollars per share)     7.14   3.06
Exercises in period, weighted average exercise price (in dollars per share)     7.42   2.92
Forfeitures in period, weighted average exercise price (in dollars per share)     5.91   5.18
Expirations in period, weighted average exercise price (in dollars per share)     15.61   5.22
Weighted average exercise price, end of period (in dollars per share) 7.42   7.42   $ 15.61
Exercisable options, weighted average exercise price (in dollars per share) $ 7.42   $ 7.42    
Maximum | Employee Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Exercisable options, weighted average remaining contractual term     10 years    
Equity Option          
Number of Shares          
Number of nonvested shares, beginning of period (in shares)     403,990    
Granted, nonvested, number of shares (in shares)     169,210    
Vested, number of shares (in shares)     (350,774)    
Nonvested options forfeited, number of shares (in shares)     (8,049)    
Number of nonvested shares, end of period (in shares) 214,377   214,377   403,990
Weighted Average Grant Date Fair Value          
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 0.94    
Granted, nonvested, weighted average grant date fair value (in dollars per share)     2.06    
Vested, weighted average grant date fair value (in dollars per share)     1.23    
Nonvested options forfeited, weighted average grant date fair value (in dollars per share)     1.60    
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 1.34   $ 1.34   $ 0.94